{"product_id":"gonadorelin-10mg-vial","title":"Gonadorelin 10mg vial","description":"\u003ch3\u003e\n\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cstrong\u003e                                   \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/strong\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eFOR HUMAN \u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003e\u003cstrong\u003eCONSUMPTION\u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\n\u003c\/h3\u003e\n\u003cp data-end=\"871\" data-start=\"58\"\u003e\u003cstrong\u003eGonadorelin\u003c\/strong\u003e is the synthetic form of endogenous \u003cstrong data-end=\"186\" data-start=\"139\"\u003egonadotropin-releasing hormone (GnRH, LHRH)\u003c\/strong\u003e—a decapeptide secreted in \u003cstrong data-end=\"223\" data-start=\"213\"\u003epulses\u003c\/strong\u003e by the hypothalamus. It binds \u003cstrong data-end=\"272\" data-start=\"254\"\u003eGnRH receptors\u003c\/strong\u003e on pituitary gonadotrophs to trigger \u003cstrong data-end=\"338\" data-start=\"310\"\u003eluteinizing hormone (LH)\u003c\/strong\u003e and \u003cstrong data-end=\"381\" data-start=\"343\"\u003efollicle-stimulating hormone (FSH)\u003c\/strong\u003e release, which in turn regulate \u003cstrong data-end=\"440\" data-start=\"414\"\u003esex-steroid production\u003c\/strong\u003e and \u003cstrong data-end=\"462\" data-start=\"445\"\u003egametogenesis\u003c\/strong\u003e. Clinically, gonadorelin is \u003cstrong data-end=\"544\" data-start=\"491\"\u003eapproved in several regions as a diagnostic agent\u003c\/strong\u003e for assessing pituitary gonadotroph function (e.g., delayed puberty, amenorrhea, hypogonadism). Therapeutically, \u003cstrong data-end=\"680\" data-start=\"658\"\u003epulsatile infusion\u003c\/strong\u003e can restore fertility in \u003cstrong data-end=\"735\" data-start=\"706\"\u003ehypothalamic hypogonadism\u003c\/strong\u003e; continuous exposure desensitizes the receptor (the basis of long-acting GnRH-agonist therapy), but gonadorelin itself is short-acting.\u003c\/p\u003e\n\u003chr data-end=\"876\" data-start=\"873\"\u003e\n\u003ch3 data-end=\"940\" data-start=\"878\"\u003eAdditional Benefits of Gonadorelin Now Under Investigation\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"3711\" data-start=\"942\"\u003e\n\u003cthead data-end=\"970\" data-start=\"942\"\u003e\n\u003ctr data-end=\"970\" data-start=\"942\"\u003e\n\u003cth data-col-size=\"md\" data-end=\"952\" data-start=\"942\"\u003eBenefit\u003c\/th\u003e\n\u003cth data-col-size=\"xl\" data-end=\"970\" data-start=\"952\"\u003eKey take-aways\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"3711\" data-start=\"981\"\u003e\n\u003ctr data-end=\"1297\" data-start=\"981\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1038\" data-start=\"981\"\u003e\u003cstrong data-end=\"1037\" data-start=\"983\"\u003e1 Physiologic ovulation in hypothalamic amenorrhea\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1297\" data-start=\"1038\"\u003e\n\u003cstrong data-end=\"1081\" data-start=\"1040\"\u003ePulsatile SC\/IV delivery (q60–90 min)\u003c\/strong\u003e reconstitutes LH\/FSH pulsatility, yielding \u003cstrong data-end=\"1198\" data-start=\"1125\"\u003emono-follicular ovulation with a low multiple-gestation and OHSS risk\u003c\/strong\u003e compared with exogenous gonadotropins. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Fertility and Sterility; Human Reproduction\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1648\" data-start=\"1298\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1365\" data-start=\"1298\"\u003e\u003cstrong data-end=\"1364\" data-start=\"1300\"\u003e2 Restoration of spermatogenesis in congenital\/functional HH\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1648\" data-start=\"1365\"\u003eIn men with \u003cstrong data-end=\"1415\" data-start=\"1379\"\u003eGnRH deficiency (e.g., Kallmann)\u003c\/strong\u003e or functional hypothalamic suppression, pulsatile therapy \u003cstrong data-end=\"1525\" data-start=\"1474\"\u003einitiates testicular growth and spermatogenesis\u003c\/strong\u003e, providing a physiologic alternative to hCG\/hMG. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Journal of Clinical Endocrinology \u0026amp; Metabolism; Andrology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1941\" data-start=\"1649\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1720\" data-start=\"1649\"\u003e\u003cstrong data-end=\"1719\" data-start=\"1651\"\u003e3 Diagnostic discrimination of hypothalamic vs pituitary disease\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1941\" data-start=\"1720\"\u003e\n\u003cstrong data-end=\"1751\" data-start=\"1722\"\u003eSingle-bolus GnRH testing\u003c\/strong\u003e (e.g., 100 µg IV) helps differentiate \u003cstrong data-end=\"1823\" data-start=\"1790\"\u003epituitary gonadotroph failure\u003c\/strong\u003e(blunted LH\/FSH) from \u003cstrong data-end=\"1869\" data-start=\"1846\"\u003ehypothalamic causes\u003c\/strong\u003e (delayed but present response). \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Endocrine Reviews; JCEM\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2267\" data-start=\"1942\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1995\" data-start=\"1942\"\u003e\u003cstrong data-end=\"1994\" data-start=\"1944\"\u003e4 Luteal-phase optimization in restored cycles\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2267\" data-start=\"1995\"\u003eWith pulsatile induction, luteal function is often adequate; when suboptimal, \u003cstrong data-end=\"2111\" data-start=\"2075\"\u003ephysiologic progesterone support\u003c\/strong\u003e can normalize implantation milieu while maintaining \u003cstrong data-end=\"2193\" data-start=\"2164\"\u003elow hyperstimulation risk\u003c\/strong\u003e. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Reproductive BioMedicine Online; Obstetrics \u0026amp; Gynecology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2564\" data-start=\"2268\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2327\" data-start=\"2268\"\u003e\u003cstrong data-end=\"2326\" data-start=\"2270\"\u003e5 Lower cumulative iatrogenic risks vs gonadotropins\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2564\" data-start=\"2327\"\u003ePhysiologic follicular recruitment reduces \u003cstrong data-end=\"2396\" data-start=\"2372\"\u003emultifetal pregnancy\u003c\/strong\u003e, \u003cstrong data-end=\"2420\" data-start=\"2398\"\u003ecycle cancellation\u003c\/strong\u003e, and \u003cstrong data-end=\"2434\" data-start=\"2426\"\u003eOHSS\u003c\/strong\u003e, potentially improving \u003cstrong data-end=\"2482\" data-start=\"2458\"\u003esafety-per-pregnancy\u003c\/strong\u003e metrics in HH. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Fertility and Sterility; Human Reproduction Update\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2895\" data-start=\"2565\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2633\" data-start=\"2565\"\u003e\u003cstrong data-end=\"2632\" data-start=\"2567\"\u003e6 Functional hypothalamic amenorrhea (FHA) in athletes\/stress\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2895\" data-start=\"2633\"\u003eIn FHA refractory to lifestyle intervention, \u003cstrong data-end=\"2708\" data-start=\"2680\"\u003etemporary pulsatile GnRH\u003c\/strong\u003e can \u003cstrong data-end=\"2736\" data-start=\"2713\"\u003ere-establish cycles\u003c\/strong\u003eand mitigate hypoestrogenic sequelae (bone, urogenital) without supraphysiologic gonadotropin exposure. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Sports Medicine; Endocrine Connections\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3160\" data-start=\"2896\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2929\" data-start=\"2896\"\u003e\u003cstrong data-end=\"2928\" data-start=\"2898\"\u003e7 Pubertal axis assessment\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"3160\" data-start=\"2929\"\u003eIn \u003cstrong data-end=\"2966\" data-start=\"2934\"\u003edelayed or ambiguous puberty\u003c\/strong\u003e, GnRH testing—alone or with \u003cstrong data-end=\"3018\" data-start=\"2995\"\u003esex-steroid priming\u003c\/strong\u003e—improves diagnostic yield and \u003cstrong data-end=\"3097\" data-start=\"3049\"\u003erisk-stratifies for progression vs pathology\u003c\/strong\u003e. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Pediatrics; European Journal of Endocrinology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3410\" data-start=\"3161\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3205\" data-start=\"3161\"\u003e\u003cstrong data-end=\"3204\" data-start=\"3163\"\u003e8 Post-pituitary surgery surveillance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"3410\" data-start=\"3205\"\u003eSerial GnRH tests can \u003cstrong data-end=\"3258\" data-start=\"3229\"\u003etrack gonadotroph reserve\u003c\/strong\u003e during recovery after pituitary adenoma therapy, complementing basal gonadotropins and inhibin B\/AMH. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Pituitary; Clinical Endocrinology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3711\" data-start=\"3411\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3462\" data-start=\"3411\"\u003e\u003cstrong data-end=\"3461\" data-start=\"3413\"\u003e9 Research tool for frequency-coding biology\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"3711\" data-start=\"3462\"\u003eControlled \u003cstrong data-end=\"3505\" data-start=\"3475\"\u003epulse-frequency modulation\u003c\/strong\u003e (faster → LH-biased, slower → FSH-biased) enables study of \u003cstrong data-end=\"3603\" data-start=\"3565\"\u003egonadotropin subunit transcription\u003c\/strong\u003e and personalized induction paradigms. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Nature Reviews Endocrinology; Molecular Endocrinology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"3716\" data-start=\"3713\"\u003e\n\u003ch2 data-end=\"3753\" data-start=\"3718\"\u003e2. Molecular Mechanism of Action\u003c\/h2\u003e\n\u003ch3 data-end=\"3790\" data-start=\"3755\"\u003e2.1 Receptor Pharmacodynamics\u003c\/h3\u003e\n\u003cp data-end=\"4003\" data-start=\"3791\"\u003eGonadorelin binds the \u003cstrong data-end=\"3834\" data-start=\"3813\"\u003eGnRH (GNRHR) GPCR\u003c\/strong\u003e on pituitary gonadotrophs → \u003cstrong data-end=\"3895\" data-start=\"3863\"\u003eGαq\/11–PLCβ–IP₃\/DAG–Ca²⁺\/PKC\u003c\/strong\u003esignalling → exocytosis of \u003cstrong data-end=\"3944\" data-start=\"3923\"\u003epre-formed LH\/FSH\u003c\/strong\u003e and transcriptional up-regulation of \u003cstrong data-end=\"4000\" data-start=\"3982\"\u003eCGA, LHB, FSHB\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cul data-end=\"4220\" data-start=\"4004\"\u003e\n\u003cli data-end=\"4109\" data-start=\"4004\"\u003e\n\u003cp data-end=\"4109\" data-start=\"4006\"\u003e\u003cstrong data-end=\"4028\" data-start=\"4006\"\u003ePulsatile exposure\u003c\/strong\u003e preserves receptor responsiveness and \u003cstrong data-end=\"4086\" data-start=\"4067\"\u003efrequency-codes\u003c\/strong\u003e LH vs FSH synthesis.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4220\" data-start=\"4110\"\u003e\n\u003cp data-end=\"4220\" data-start=\"4112\"\u003e\u003cstrong data-end=\"4135\" data-start=\"4112\"\u003eContinuous exposure\u003c\/strong\u003e leads to receptor \u003cstrong data-end=\"4189\" data-start=\"4154\"\u003edesensitization\/internalization\u003c\/strong\u003e and \u003cstrong data-end=\"4209\" data-start=\"4194\"\u003esuppression\u003c\/strong\u003e of LH\/FSH.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-end=\"4249\" data-start=\"4222\"\u003e2.2 Down-stream Biology\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"4693\" data-start=\"4251\"\u003e\n\u003cthead data-end=\"4293\" data-start=\"4251\"\u003e\n\u003ctr data-end=\"4293\" data-start=\"4251\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"4261\" data-start=\"4251\"\u003ePathway\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"4282\" data-start=\"4261\"\u003eFunctional outcome\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"4293\" data-start=\"4282\"\u003eContext\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"4693\" data-start=\"4308\"\u003e\n\u003ctr data-end=\"4410\" data-start=\"4308\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4329\" data-start=\"4308\"\u003eIP₃\/Ca²⁺, PKC, ERK\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4397\" data-start=\"4329\"\u003eAcute LH\/FSH release; gene transcription of gonadotropin subunits\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4410\" data-start=\"4397\"\u003ePituitary\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4511\" data-start=\"4411\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4431\" data-start=\"4411\"\u003eLH → theca\/Leydig\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4495\" data-start=\"4431\"\u003e↑ Androgen (substrate for estradiol; testosterone production)\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4511\" data-start=\"4495\"\u003eOvary\/testis\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4609\" data-start=\"4512\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4538\" data-start=\"4512\"\u003eFSH → granulosa\/Sertoli\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4593\" data-start=\"4538\"\u003eFolliculogenesis, aromatase; spermatogenesis support\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4609\" data-start=\"4593\"\u003eOvary\/testis\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4693\" data-start=\"4610\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4629\" data-start=\"4610\"\u003eSteroid feedback\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4681\" data-start=\"4629\"\u003eE2\/T, inhibin, progesterone fine-tune GnRH\/LH\/FSH\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4693\" data-start=\"4681\"\u003eHPG axis\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"4698\" data-start=\"4695\"\u003e\n\u003ch2 data-end=\"4722\" data-start=\"4700\"\u003e3. Pharmacokinetics\u003c\/h2\u003e\n\u003cul data-end=\"5113\" data-start=\"4724\"\u003e\n\u003cli data-end=\"4811\" data-start=\"4724\"\u003e\n\u003cp data-end=\"4811\" data-start=\"4726\"\u003e\u003cstrong data-end=\"4736\" data-start=\"4726\"\u003eRoute:\u003c\/strong\u003e IV\/SC for testing; \u003cstrong data-end=\"4778\" data-start=\"4756\"\u003epulsatile SC or IV\u003c\/strong\u003e via portable pump for therapy.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4899\" data-start=\"4812\"\u003e\n\u003cp data-end=\"4899\" data-start=\"4814\"\u003e\u003cstrong data-end=\"4829\" data-start=\"4814\"\u003eOnset\/peak:\u003c\/strong\u003e LH rises within \u003cstrong data-end=\"4860\" data-start=\"4846\"\u003e~15–30 min\u003c\/strong\u003e of a bolus; FSH lag modestly longer.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5018\" data-start=\"4900\"\u003e\n\u003cp data-end=\"5018\" data-start=\"4902\"\u003e\u003cstrong data-end=\"4916\" data-start=\"4902\"\u003eHalf-life:\u003c\/strong\u003e \u003cstrong data-end=\"4938\" data-start=\"4917\"\u003e~2–4 minutes (IV)\u003c\/strong\u003e; short systemic exposure mandates \u003cstrong data-end=\"4995\" data-start=\"4973\"\u003epulsatile delivery\u003c\/strong\u003e for therapeutic use.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5113\" data-start=\"5019\"\u003e\n\u003cp data-end=\"5113\" data-start=\"5021\"\u003e\u003cstrong data-end=\"5035\" data-start=\"5021\"\u003eClearance:\u003c\/strong\u003e Peptidase degradation; renal\/hepatic peptide catabolism; no CYP interactions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"5118\" data-start=\"5115\"\u003e\n\u003ch2 data-end=\"5165\" data-start=\"5120\"\u003e4. Pre-clinical and Translational Evidence\u003c\/h2\u003e\n\u003ch3 data-end=\"5209\" data-start=\"5167\"\u003e4.1 Female Hypothalamic Hypogonadism\u003c\/h3\u003e\n\u003cp data-end=\"5407\" data-start=\"5210\"\u003ePulsatile GnRH achieves \u003cstrong data-end=\"5272\" data-start=\"5234\"\u003ehigh ovulation and pregnancy rates\u003c\/strong\u003e with \u003cstrong data-end=\"5303\" data-start=\"5278\"\u003emonofollicular cycles\u003c\/strong\u003e and \u003cstrong data-end=\"5325\" data-start=\"5308\"\u003every low OHSS\u003c\/strong\u003e, often favored when a physiologic approach is desired or when \u003cstrong data-end=\"5406\" data-start=\"5388\"\u003ePCOS is absent\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch3 data-end=\"5453\" data-start=\"5409\"\u003e4.2 Male Hypogonadotropic Hypogonadism\u003c\/h3\u003e\n\u003cp data-end=\"5680\" data-start=\"5454\"\u003eIn congenital GnRH deficiency and functional HH, pulsatile therapy \u003cstrong data-end=\"5562\" data-start=\"5521\"\u003erestores intratesticular testosterone\u003c\/strong\u003e, \u003cstrong data-end=\"5589\" data-start=\"5564\"\u003eSertoli cell function\u003c\/strong\u003e, and \u003cstrong data-end=\"5614\" data-start=\"5595\"\u003espermatogenesis\u003c\/strong\u003e; time-to-sperm varies by onset\/severity and prior cryptorchidism.\u003c\/p\u003e\n\u003ch3 data-end=\"5703\" data-start=\"5682\"\u003e4.3 Diagnostics\u003c\/h3\u003e\n\u003cp data-end=\"5949\" data-start=\"5704\"\u003eStandardized \u003cstrong data-end=\"5747\" data-start=\"5717\"\u003eGnRH stimulation protocols\u003c\/strong\u003e assist in \u003cstrong data-end=\"5777\" data-start=\"5758\"\u003edelayed puberty\u003c\/strong\u003e, \u003cstrong data-end=\"5793\" data-start=\"5779\"\u003eamenorrhea\u003c\/strong\u003e, \u003cstrong data-end=\"5833\" data-start=\"5795\"\u003epost-surgical pituitary assessment\u003c\/strong\u003e, and \u003cstrong data-end=\"5884\" data-start=\"5839\"\u003ecentral precocious puberty (historically)\u003c\/strong\u003e—now often replaced by long-acting agonist tests where available.\u003c\/p\u003e\n\u003chr data-end=\"5954\" data-start=\"5951\"\u003e\n\u003ch2 data-end=\"5989\" data-start=\"5956\"\u003e5. Emerging Clinical Interests\u003c\/h2\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"6540\" data-start=\"5991\"\u003e\n\u003cthead data-end=\"6029\" data-start=\"5991\"\u003e\n\u003ctr data-end=\"6029\" data-start=\"5991\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"5999\" data-start=\"5991\"\u003eField\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"6011\" data-start=\"5999\"\u003eRationale\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"6029\" data-start=\"6011\"\u003eCurrent status\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"6540\" data-start=\"6044\"\u003e\n\u003ctr data-end=\"6198\" data-start=\"6044\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6076\" data-start=\"6044\"\u003e\u003cstrong data-end=\"6075\" data-start=\"6046\"\u003eFunctional HA in athletes\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6132\" data-start=\"6076\"\u003eReversible hypothalamic suppression; fertility desire\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6198\" data-start=\"6132\"\u003eSpecialized centers use pulsatile therapy after lifestyle care\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6310\" data-start=\"6199\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6231\" data-start=\"6199\"\u003e\u003cstrong data-end=\"6230\" data-start=\"6201\"\u003ePersonalized pulse-coding\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6270\" data-start=\"6231\"\u003eTitrate LH\/FSH balance via frequency\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6310\" data-start=\"6270\"\u003eUnder investigation with smart pumps\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6421\" data-start=\"6311\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6349\" data-start=\"6311\"\u003e\u003cstrong data-end=\"6348\" data-start=\"6313\"\u003eOncofertility (post-therapy HH)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6394\" data-start=\"6349\"\u003eAxis reconstitution after cranial RT\/chemo\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6421\" data-start=\"6394\"\u003eCase-series\/feasibility\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6540\" data-start=\"6422\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6459\" data-start=\"6422\"\u003e\u003cstrong data-end=\"6458\" data-start=\"6424\"\u003eAssisted reproduction adjuncts\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6511\" data-start=\"6459\"\u003ePhysiologic trigger strategies and luteal support\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6540\" data-start=\"6511\"\u003eNiche, protocol-dependent\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"6545\" data-start=\"6542\"\u003e\n\u003ch2 data-end=\"6576\" data-start=\"6547\"\u003e6. Safety and Tolerability\u003c\/h2\u003e\n\u003cul data-end=\"7185\" data-start=\"6578\"\u003e\n\u003cli data-end=\"6691\" data-start=\"6578\"\u003e\n\u003cp data-end=\"6691\" data-start=\"6580\"\u003e\u003cstrong data-end=\"6591\" data-start=\"6580\"\u003eCommon:\u003c\/strong\u003e Flushing, headache, transient lower abdominal discomfort; \u003cstrong data-end=\"6677\" data-start=\"6650\"\u003einjection-site erythema\u003c\/strong\u003e with pumps.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6832\" data-start=\"6692\"\u003e\n\u003cp data-end=\"6832\" data-start=\"6694\"\u003e\u003cstrong data-end=\"6718\" data-start=\"6694\"\u003eCycle risks (women):\u003c\/strong\u003e \u003cstrong data-end=\"6726\" data-start=\"6719\"\u003eLow\u003c\/strong\u003e rates of \u003cstrong data-end=\"6749\" data-start=\"6736\"\u003emultiples\u003c\/strong\u003e and \u003cstrong data-end=\"6762\" data-start=\"6754\"\u003eOHSS\u003c\/strong\u003e compared with exogenous gonadotropins; monitor follicles\/estradiol.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6957\" data-start=\"6833\"\u003e\n\u003cp data-end=\"6957\" data-start=\"6835\"\u003e\u003cstrong data-end=\"6843\" data-start=\"6835\"\u003eMen:\u003c\/strong\u003e Gynecomastia uncommon; monitor \u003cstrong data-end=\"6896\" data-start=\"6875\"\u003etesticular volume\u003c\/strong\u003e, \u003cstrong data-end=\"6918\" data-start=\"6898\"\u003esperm parameters\u003c\/strong\u003e, and \u003cstrong data-end=\"6938\" data-start=\"6924\"\u003ehematocrit\u003c\/strong\u003e as T normalizes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7091\" data-start=\"6958\"\u003e\n\u003cp data-end=\"7091\" data-start=\"6960\"\u003e\u003cstrong data-end=\"6982\" data-start=\"6960\"\u003eContraindications:\u003c\/strong\u003e Pregnancy, hormone-sensitive malignancy, uncontrolled pituitary disease, hypersensitivity to GnRH\/analogs.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7185\" data-start=\"7092\"\u003e\n\u003cp data-end=\"7185\" data-start=\"7094\"\u003e\u003cstrong data-end=\"7110\" data-start=\"7094\"\u003eOperational:\u003c\/strong\u003e Pump therapy requires \u003cstrong data-end=\"7154\" data-start=\"7133\"\u003easeptic technique\u003c\/strong\u003e, catheter care, and adherence.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"7216\" data-start=\"7187\"\u003e\u003cstrong data-end=\"7216\" data-start=\"7187\"\u003eComparative safety matrix\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"7749\" data-start=\"7218\"\u003e\n\u003cthead data-end=\"7335\" data-start=\"7218\"\u003e\n\u003ctr data-end=\"7335\" data-start=\"7218\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"7228\" data-start=\"7218\"\u003eConcern\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"7258\" data-start=\"7228\"\u003e\u003cstrong data-end=\"7257\" data-start=\"7230\"\u003eGonadorelin (pulsatile)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"7302\" data-start=\"7258\"\u003e\u003cstrong data-end=\"7301\" data-start=\"7260\"\u003eExogenous gonadotropins (hMG\/FSH+hCG)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"7335\" data-start=\"7302\"\u003e\u003cstrong data-end=\"7333\" data-start=\"7304\"\u003eLong-acting GnRH agonists\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"7749\" data-start=\"7354\"\u003e\n\u003ctr data-end=\"7448\" data-start=\"7354\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7383\" data-start=\"7354\"\u003ePhysiologic LH\/FSH pattern\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7407\" data-start=\"7383\"\u003e\u003cstrong data-end=\"7406\" data-start=\"7385\"\u003eYes (pulse-coded)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7428\" data-start=\"7407\"\u003eNo (pharmacologic)\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"7448\" data-start=\"7428\"\u003eNo (suppression)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7519\" data-start=\"7449\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7479\" data-start=\"7449\"\u003eMultiples\/OHSS in induction\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7489\" data-start=\"7479\"\u003e\u003cstrong data-end=\"7488\" data-start=\"7481\"\u003eLow\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7498\" data-start=\"7489\"\u003eHigher\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"7519\" data-start=\"7498\"\u003eN\/A (suppressive)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7614\" data-start=\"7520\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7534\" data-start=\"7520\"\u003eConvenience\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7557\" data-start=\"7534\"\u003ePump\/catheter burden\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7582\" data-start=\"7557\"\u003eInjections but simpler\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"7614\" data-start=\"7582\"\u003eInjections monthly\/3-monthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7749\" data-start=\"7615\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7629\" data-start=\"7615\"\u003eTypical use\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7667\" data-start=\"7629\"\u003eHH fertility induction; diagnostics\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7700\" data-start=\"7667\"\u003eBroad ovulation induction; ART\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"7749\" data-start=\"7700\"\u003eSuppression (endometriosis, CPP, prostate Ca)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"7754\" data-start=\"7751\"\u003e\n\u003ch2 data-end=\"7782\" data-start=\"7756\"\u003e7. Regulatory Landscape\u003c\/h2\u003e\n\u003cul data-end=\"8189\" data-start=\"7784\"\u003e\n\u003cli data-end=\"7911\" data-start=\"7784\"\u003e\n\u003cp data-end=\"7911\" data-start=\"7786\"\u003e\u003cstrong data-end=\"7825\" data-start=\"7786\"\u003eApproved indication (many regions):\u003c\/strong\u003e \u003cstrong data-end=\"7848\" data-start=\"7826\"\u003eDiagnostic testing\u003c\/strong\u003e of pituitary gonadotroph function (e.g., single-dose IV\/SC).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8102\" data-start=\"7912\"\u003e\n\u003cp data-end=\"8102\" data-start=\"7914\"\u003e\u003cstrong data-end=\"7934\" data-start=\"7914\"\u003eTherapeutic use:\u003c\/strong\u003e \u003cstrong data-end=\"7953\" data-start=\"7935\"\u003ePulsatile GnRH\u003c\/strong\u003e for hypothalamic hypogonadism–related infertility practiced in specialized centers; availability varies by \u003cstrong data-end=\"8099\" data-start=\"8061\"\u003edevice access and local regulation\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8189\" data-start=\"8103\"\u003e\n\u003cp data-end=\"8189\" data-start=\"8105\"\u003e\u003cstrong data-end=\"8122\" data-start=\"8105\"\u003eNot indicated\u003c\/strong\u003e as chronic suppressive therapy—long-acting analogs fill that role.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"8194\" data-start=\"8191\"\u003e\n\u003ch2 data-end=\"8219\" data-start=\"8196\"\u003e8. Future Directions\u003c\/h2\u003e\n\u003cul data-end=\"8718\" data-start=\"8221\"\u003e\n\u003cli data-end=\"8346\" data-start=\"8221\"\u003e\n\u003cp data-end=\"8346\" data-start=\"8223\"\u003e\u003cstrong data-end=\"8259\" data-start=\"8223\"\u003eSmart pumps \u0026amp; closed-loop dosing\u003c\/strong\u003e using real-time LH feedback to \u003cstrong data-end=\"8319\" data-start=\"8291\"\u003eoptimize pulse frequency\u003c\/strong\u003e and minimize monitoring.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8464\" data-start=\"8347\"\u003e\n\u003cp data-end=\"8464\" data-start=\"8349\"\u003e\u003cstrong data-end=\"8411\" data-start=\"8349\"\u003eIntegration with lifestyle\/energy-availability restoration\u003c\/strong\u003e in FHA to shorten time-to-menses and protect bone.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8596\" data-start=\"8465\"\u003e\n\u003cp data-end=\"8596\" data-start=\"8467\"\u003e\u003cstrong data-end=\"8487\" data-start=\"8467\"\u003eBiomarker panels\u003c\/strong\u003e (kisspeptin, inhibin B\/AMH) to refine \u003cstrong data-end=\"8559\" data-start=\"8526\"\u003ediagnosis and prognostication\u003c\/strong\u003e before committing to pump therapy.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8718\" data-start=\"8597\"\u003e\n\u003cp data-end=\"8718\" data-start=\"8599\"\u003e\u003cstrong data-end=\"8617\" data-start=\"8599\"\u003eMale protocols\u003c\/strong\u003e combining \u003cstrong data-end=\"8659\" data-start=\"8628\"\u003epulsatile GnRH with hCG\/FSH\u003c\/strong\u003e to accelerate spermatogenic recovery in select phenotypes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"8723\" data-start=\"8720\"\u003e\n\u003ch3 data-end=\"8748\" data-start=\"8725\"\u003eSelected References\u003c\/h3\u003e\n\u003cul data-end=\"9963\" data-start=\"8750\"\u003e\n\u003cli data-end=\"8953\" data-start=\"8750\"\u003e\n\u003cp data-end=\"8953\" data-start=\"8752\"\u003eCrowley W.F., Filicori M., et al. \u003cstrong data-end=\"8874\" data-start=\"8786\"\u003ePulsatile GnRH therapy in hypothalamic amenorrhea and hypogonadotropic hypogonadism.\u003c\/strong\u003e \u003cem data-end=\"8923\" data-start=\"8875\"\u003eJournal of Clinical Endocrinology \u0026amp; Metabolism\u003c\/em\u003e; \u003cem data-end=\"8950\" data-start=\"8925\"\u003eFertility and Sterility\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9094\" data-start=\"8954\"\u003e\n\u003cp data-end=\"9094\" data-start=\"8956\"\u003eHall J.E., Hayes F.J. \u003cstrong data-end=\"9044\" data-start=\"8978\"\u003ePhysiology of GnRH pulse frequency and gonadotropin synthesis.\u003c\/strong\u003e \u003cem data-end=\"9064\" data-start=\"9045\"\u003eEndocrine Reviews\u003c\/em\u003e; \u003cem data-end=\"9091\" data-start=\"9066\"\u003eMolecular Endocrinology\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9203\" data-start=\"9095\"\u003e\n\u003cp data-end=\"9203\" data-start=\"9097\"\u003eBouchard P., et al. \u003cstrong data-end=\"9179\" data-start=\"9117\"\u003eDiagnostic use of the GnRH (gonadorelin) stimulation test.\u003c\/strong\u003e \u003cem data-end=\"9186\" data-start=\"9180\"\u003eJCEM\u003c\/em\u003e; \u003cem data-end=\"9200\" data-start=\"9188\"\u003ePediatrics\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9346\" data-start=\"9204\"\u003e\n\u003cp data-end=\"9346\" data-start=\"9206\"\u003eMartin K.A., et al. \u003cstrong data-end=\"9290\" data-start=\"9226\"\u003eFunctional hypothalamic amenorrhea—diagnosis and management.\u003c\/strong\u003e \u003cem data-end=\"9318\" data-start=\"9291\"\u003eHuman Reproduction Update\u003c\/em\u003e; \u003cem data-end=\"9343\" data-start=\"9320\"\u003eEndocrine Connections\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9471\" data-start=\"9347\"\u003e\n\u003cp data-end=\"9471\" data-start=\"9349\"\u003ePitteloud N., et al. \u003cstrong data-end=\"9448\" data-start=\"9370\"\u003eKallmann syndrome and congenital GnRH deficiency—restoration of fertility.\u003c\/strong\u003e \u003cem data-end=\"9460\" data-start=\"9449\"\u003eAndrology\u003c\/em\u003e; \u003cem data-end=\"9468\" data-start=\"9462\"\u003eJCEM\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9611\" data-start=\"9472\"\u003e\n\u003cp data-end=\"9611\" data-start=\"9474\"\u003eTarlatzis B.C., et al. \u003cstrong data-end=\"9552\" data-start=\"9497\"\u003eOvulation induction strategies and OHSS prevention.\u003c\/strong\u003e \u003cem data-end=\"9573\" data-start=\"9553\"\u003eHuman Reproduction\u003c\/em\u003e; \u003cem data-end=\"9608\" data-start=\"9575\"\u003eReproductive BioMedicine Online\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9732\" data-start=\"9612\"\u003e\n\u003cp data-end=\"9732\" data-start=\"9614\"\u003eMelmed S., et al. \u003cstrong data-end=\"9691\" data-start=\"9632\"\u003ePituitary disease evaluation and post-surgical testing.\u003c\/strong\u003e \u003cem data-end=\"9716\" data-start=\"9692\"\u003eClinical Endocrinology\u003c\/em\u003e; \u003cem data-end=\"9729\" data-start=\"9718\"\u003ePituitary\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9824\" data-start=\"9733\"\u003e\n\u003cp data-end=\"9824\" data-start=\"9735\"\u003ePlant T.M., Marshall J.C. \u003cstrong data-end=\"9801\" data-start=\"9761\"\u003ePuberty and GnRH neuroendocrinology.\u003c\/strong\u003e \u003cem data-end=\"9821\" data-start=\"9802\"\u003eEndocrine Reviews\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9963\" data-start=\"9825\"\u003e\n\u003cp data-end=\"9963\" data-start=\"9827\"\u003eWelt C.K., et al. \u003cstrong data-end=\"9909\" data-start=\"9845\"\u003eLuteal support and implantation after physiologic induction.\u003c\/strong\u003e \u003cem data-end=\"9935\" data-start=\"9910\"\u003eObstetrics \u0026amp; Gynecology\u003c\/em\u003e; \u003cem data-end=\"9962\" data-start=\"9937\"\u003eFertility and Sterility\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"RCpeptides","offers":[{"title":"Default Title","offer_id":52684854264146,"sku":null,"price":50.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/gonadorelin_10mg.png?v=1770834873","url":"https:\/\/sciencepeptideslab.com\/products\/gonadorelin-10mg-vial","provider":"Science Peptides Lab","version":"1.0","type":"link"}